Data protection Impressum

Healthcare

Switzerland has long been known as a global hub for cutting-edge innovation, and the recent visit of the Club de Paris des Directeurs de l'Innovation provided a unique opportunity to showcase the vibrant ecosystem in Western Switzerland. Co-organized by Greater Geneva Bern area (GGBa), this three-day learning journey brought together leaders and innovators from various sectors, eager to explore and exchange ideas on technological advancement and collaboration.

Business environment

Discovering Swiss Innovation with the Club de Paris des Directeurs de l’Innovation

21 October 2024

Researchers at the University of Bern and the Bern University Hospital have developed a new test that simplifies and improves the accuracy of allergy diagnosis.

Allergy test developed by Bern researchers shows higher accuracy in diagnosing food allergies

15 October 2024

Lymphatica Medtech, a Lausanne-based clinical-stage company specializing in innovative treatments for lymphedema, has raised EUR 17.9 million in a Series B funding round.

Lymphatica Medtech secures EUR 17.9 million to advance lymphedema treatment

15 October 2024

The canton of Fribourg, together with the Banque Cantonale de Fribourg (BCF), has revealed the nine finalists of the prestigious IFF (Innovation Fribourg Freiburg) Awards.

Fribourg unveils nine finalists for the 2024-2025 IFF Innovation Awards

15 October 2024

machineMD has received EU-MDR Class IIa certification for its neos™ neuro-ophthalmic diagnostic device, setting a new standard for eye movement and pupil function assessment in neurology and ophthalmology.

machineMD’s neos receives EU-MDR Class IIa Certification to advance neuro-ophthalmic diagnostics

14 October 2024

Atinary Technologies and Snapdragon Chemistry, a Cambrex company, have announced a strategic collaboration to integrate AI-driven process optimization technology with advanced pharmaceutical development capabilities, aiming to revolutionize drug development.

Atinary Technologies and Snapdragon Chemistry partner to optimize drug development with AI

9 October 2024

Phoenix Pharma Switzerland has announced the relocation of its Swiss headquarters to the Businesspark Liebefeld in Köniz, bringing 100 new jobs to the canton of Bern.

Phoenix Pharma Switzerland relocates its headquarters to the canton of Bern

2 October 2024

The newly inaugurated Genolier Innovation Hub, a 270,000-square-foot facility, offers companies, researchers and healthcare professionals an interdisciplinary platform to foster medical breakthroughs, backed by a CHF 100 million investment.

The Genolier Innovation Hub, a cutting-edge medical innovation center, was inaugurated

30 September 2024

The CHUV in Lausanne has inaugurated the state-of-the-art Swiss BioMotion Lab, which offers innovative solutions for the study and treatment of osteoarthritis through cutting-edge motion analysis.

CHUV inaugurates Swiss BioMotion Lab for advanced osteoarthritis research and treatment

23 September 2024

HAYA Therapeutics has announced a multi-year collaboration with Eli Lilly, potentially earning up to USD 1 billion in milestone payments to advance RNA-guided therapies for obesity and metabolic disorders.

HAYA Therapteutics enters major collaboration to advance RNA-based drug discovery

17 September 2024

1 2 3 4 5 6 7 8 9 10 … 16